Clinical Trials Browser

Phase 1/2 × pertuzumab × Tumor-Agnostic × Clear all

NCT04802759 2026-03-16

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Phase 1/2 Recruiting

Neoplasm Metastasis